Susquehanna International Group
ICVX

Susquehanna International Group’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Susquehanna International Group’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40,100
Closed -$398K – 13292
2023
Q2 		$398K Buy
+40,100
New +$321K ﹤0.01% 8849
2023
Q1 		– Sell
-39,800
Closed -$316K – 13813
2022
Q4 		$316K Buy
+39,800
New +$171K ﹤0.01% 8967
2022
Q3 		– Sell
-10,300
Closed -$59K – 14396
2022
Q2 		$59K Buy
+10,300
New +$80.4K ﹤0.01% 11879

Susquehanna International Group's ICVX Position: Q1 2024 in Review

Susquehanna International Group sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 13,981 shares — an estimated $220K sold.

Susquehanna International Group first reported a position in ICVX in Q1 2023 and held it in 3 quarters. The position peaked at $485K in Q1 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Susquehanna International Group reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 13,981 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $220K.
  • Susquehanna International Group first reported a position in Icosavax, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Susquehanna International Group's Icosavax, Inc. Common Stock position peaked at $485K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.